Khazanah Board Affirms Investment Gains Amid Governance Review of Life Sciences Arm
Khazanah Nasional's third board meeting for 2026 shows the sovereign wealth fund continues delivering above-target returns despite economic headwinds. However, governance irregularities at subsidiary Xeraya Capital have triggered a forensic investigation.
